비경구 영양 시장 : 영양소 유형, 제형, 최종 사용자별 - 세계 예측(2025-2030년)

The Parenteral Nutrition Market was valued at USD 7.67 billion in 2023, expected to reach USD 8.33 billion in 2024, and is projected to grow at a CAGR of 8.66%, to USD 13.73 billion by 2030.

Parenteral nutrition (PN) involves delivering nutrients directly into the bloodstream, bypassing the gastrointestinal tract, usually for patients unable to ingest or absorb enough nutrients due to medical conditions. The necessity of PN extends to patients with gastrointestinal disorders, oncology patients experiencing side effects from their treatment, and premature infants who require essential nutrients for growth and development. PN is primarily applied in hospitals, outpatient clinics, and home healthcare settings. Driven by innovations in healthcare technology and the rising prevalence of chronic diseases requiring long-term nutritional support, the market sees growing demand. Key growth drivers include the increasing rate of malnutrition and gastrointestinal diseases, advanced healthcare infrastructure, and a rise in the aging population that often requires nutritional interventions. Potential opportunities lie in the development of more efficient, safer PN formulations with enhanced patient-specific customization capabilities. Expanding access to emerging markets, where healthcare infrastructure is developing, also presents a significant growth opportunity. However, challenges such as the high cost of PN solutions, complex regulatory approvals, and risks of complications like infections and metabolic abnormalities hinder market expansion. Innovations in PN might focus on improving the bioavailability of nutrients, reducing healthcare-associated risks, and employing digital health technologies for better monitoring and administration. Research into personalized nutrition solutions, utilizing advanced data analytics and genetic information, offers a promising area for market growth. The market's nature is highly competitive, with key players constantly innovating to improve product efficacy and safety. Staying abreast of regulatory changes and technological advancements will be crucial for businesses aiming to succeed in this evolving landscape. In conclusion, the PN market holds significant potential, provided companies can navigate the existing challenges through strategic innovation and expansion into untapped regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Parenteral Nutrition Market

The Parenteral Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
  • Increasing rate of geriatric population and malnourished individuals
  • High natality and premature births around the globe
• Market Restraints
  • Strict government rules regarding the approval of parenteral nutrition
• Market Opportunities
  • Innovative parenteral and enteral nutrition therapy
  • Technological developments in parenteral nutrition
• Market Challenges
  • Associated complexities with parenteral nutrition

Porter's Five Forces: A Strategic Tool for Navigating the Parenteral Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Parenteral Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Parenteral Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Parenteral Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Parenteral Nutrition Market

A detailed market share analysis in the Parenteral Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Parenteral Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Parenteral Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Parenteral Nutrition Market

A strategic analysis of the Parenteral Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Parenteral Nutrition Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ACULIFE HEALTHCARE PRIVATE LIMITED, ALBERT DAVID LIMITED by Kothari Group, Amanta Healthcare Ltd., AMINO GmbH, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Evonik Industries AG, Fresenius Kabi AG, Grifols S.A., Hamilton Bonaduz AG, ICU Medical, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Well Pharma Medical Solutions LLC.

Market Segmentation & Coverage

This research report categorizes the Parenteral Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Nutrient Type, market is studied across Amino Acids, Carbohydrates, Electrolytes, Lipids, and Multivitamin Formulations & Trace Elements.
• Based on Dosage Form, market is studied across Ampules, Bags, Bottles, and Vials.
• Based on End-User, market is studied across Clinics, Hospitals, and Long-Term Care Providers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
    • 5.1.1.2. Increasing rate of geriatric population and malnourished individuals
    • 5.1.1.3. High natality and premature births around the globe
  • 5.1.2. Restraints
    • 5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovative parenteral and enteral nutrition therapy
    • 5.1.3.2. Technological developments in parenteral nutrition
  • 5.1.4. Challenges
    • 5.1.4.1. Associated complexities with parenteral nutrition
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Parenteral Nutrition Market, by Nutrient Type

• 6.1. Introduction
• 6.2. Amino Acids
• 6.3. Carbohydrates
• 6.4. Electrolytes
• 6.5. Lipids
• 6.6. Multivitamin Formulations & Trace Elements

7. Parenteral Nutrition Market, by Dosage Form

• 7.1. Introduction
• 7.2. Ampules
• 7.3. Bags
• 7.4. Bottles
• 7.5. Vials

8. Parenteral Nutrition Market, by End-User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals
• 8.4. Long-Term Care Providers

9. Americas Parenteral Nutrition Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Parenteral Nutrition Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Parenteral Nutrition Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. ACULIFE HEALTHCARE PRIVATE LIMITED
• 3. ALBERT DAVID LIMITED by Kothari Group
• 4. Amanta Healthcare Ltd.
• 5. AMINO GmbH
• 6. B. Braun Melsungen AG
• 7. Baxter International Inc.
• 8. Claris Lifesciences Limited
• 9. Evonik Industries AG
• 10. Fresenius Kabi AG
• 11. Grifols S.A.
• 12. Hamilton Bonaduz AG
• 13. ICU Medical, Inc.
• 14. Otsuka Holdings Co., Ltd.
• 15. Pfizer Inc.
• 16. Sichuan Kelun Pharmaceutical Co., Ltd.
• 17. Well Pharma Medical Solutions LLC